Leerink Swann initiates coverage on GlaxoSmithKline (NYSE: GSK) with a Market Perform. Price target $43-44.

Leerink analyst says, "For existing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE